Cue Biopharma (CUE) Interest Coverage Ratio (2022)

Cue Biopharma's (CUE) quarterly Interest Coverage Ratio came in at 88.96 in Q3 2022, down 40.0% quarter-over-quarter from 63.54 in Q2 2022.

Cue Biopharma (CUE) Interest Coverage Ratio (2022) Analysis & Trends

Cue Biopharma has disclosed Interest Coverage Ratio across 1 years of filings, most recently posting 88.96 for Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 3.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 11.50
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -258.33
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 547.67
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 11.79
10 Cue Biopharma 581.16 Mn 553.47 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 -88.96
Jun 30, 2022 -63.54
Mar 31, 2022 -569.52